BACKGROUND: To investigate the inhibitory role of pterostilbene in pancreatic cancer, we conducted a genomic analysis of pterostilbene-treated pancreatic cancer cells. We also investigated the effect of pterostilbene upon the carcinogenic markers, manganese superoxide dismutase, cytochrome C, Smac/DIABLO, and STAT3 phosphorylation in vitro. The antiproliferative effects of pterostilbene were further evaluated in an in vivo model. METHODS: Pancreatic cancer cells were treated with pterostilbene and evaluated with DNA microarray analysis. Pterostilbene-treated cells were analyzed for cytochrome C, Smac/DIABLO, manganese superoxide dismutase (MnSOD)/antioxidant activity, and STAT3 phosphorylation using ELISA. Data were statistically analyzed using ANOVA. Pterostilbene was then administered to nude mice for 8 weeks, and tumor growth rates were recorded and statistically analyzed. RESULTS: Microarray analysis of pterostilbene-treated cells revealed upregulation of pro-apoptosis genes. In vitro, pterostilbene treatment altered levels of phosphorylated STAT3, MnSOD/antioxidant activity, cytochrome C, and Smac/DIABLO. In nude mice, oral pterostilbene inhibited tumor growth rates. CONCLUSION: Pterostilbene alters gene expression in pancreatic cancer and increases the antiproliferative markers cytochrome C, Smac/DIABLO, and MnSOD/antioxidant activity. It was also shown to inhibit phosphorylated STAT3, a marker of accelerated tumorigenesis, and decrease pancreatic tumor growth in vivo. Further studies are warranted to elucidate the effects of pterostilbene in humans.
BACKGROUND: To investigate the inhibitory role of pterostilbene in pancreatic cancer, we conducted a genomic analysis of pterostilbene-treated pancreatic cancer cells. We also investigated the effect of pterostilbene upon the carcinogenic markers, manganese superoxide dismutase, cytochrome C, Smac/DIABLO, and STAT3 phosphorylation in vitro. The antiproliferative effects of pterostilbene were further evaluated in an in vivo model. METHODS:Pancreatic cancer cells were treated with pterostilbene and evaluated with DNA microarray analysis. Pterostilbene-treated cells were analyzed for cytochrome C, Smac/DIABLO, manganese superoxide dismutase (MnSOD)/antioxidant activity, and STAT3 phosphorylation using ELISA. Data were statistically analyzed using ANOVA. Pterostilbene was then administered to nude mice for 8 weeks, and tumor growth rates were recorded and statistically analyzed. RESULTS: Microarray analysis of pterostilbene-treated cells revealed upregulation of pro-apoptosis genes. In vitro, pterostilbene treatment altered levels of phosphorylated STAT3, MnSOD/antioxidant activity, cytochrome C, and Smac/DIABLO. In nude mice, oral pterostilbene inhibited tumor growth rates. CONCLUSION:Pterostilbene alters gene expression in pancreatic cancer and increases the antiproliferative markers cytochrome C, Smac/DIABLO, and MnSOD/antioxidant activity. It was also shown to inhibit phosphorylated STAT3, a marker of accelerated tumorigenesis, and decrease pancreatic tumor growth in vivo. Further studies are warranted to elucidate the effects of pterostilbene in humans.
Authors: Laleh Golkar; Xian-Zhong Ding; Michael B Ujiki; Mohammad R Salabat; David L Kelly; Denise Scholtens; Angela J Fought; David J Bentrem; Mark S Talamonti; Richard H Bell; Thomas E Adrian Journal: J Surg Res Date: 2007-01-25 Impact factor: 2.192
Authors: Christine Weydert; Benjamin Roling; Jingru Liu; Marilyn M Hinkhouse; Justine M Ritchie; Larry W Oberley; Joseph J Cullen Journal: Mol Cancer Ther Date: 2003-04 Impact factor: 6.261
Authors: Pascal O Berberat; Zilvinas Dambrauskas; Antanas Gulbinas; Thomas Giese; Nathalia Giese; Beat Künzli; Frank Autschbach; Stefen Meuer; Markus W Büchler; Helmut Friess Journal: Clin Cancer Res Date: 2005-05-15 Impact factor: 12.531
Authors: Matthew Ough; Anne Lewis; Yuping Zhang; Marilyn M Hinkhouse; Justine M Ritchie; Larry W Oberley; Joseph J Cullen Journal: Free Radic Res Date: 2004-11
Authors: Joseph J Cullen; Christine Weydert; Marilyn M Hinkhouse; Justine Ritchie; Frederick E Domann; Douglas Spitz; Larry W Oberley Journal: Cancer Res Date: 2003-03-15 Impact factor: 12.701
Authors: Arne Scholz; Sandra Heinze; Katharina M Detjen; Michael Peters; Martina Welzel; Peter Hauff; Michael Schirner; Bertram Wiedenmann; Stefan Rosewicz Journal: Gastroenterology Date: 2003-09 Impact factor: 22.682
Authors: J Antoni Sirerol; María L Rodríguez; Salvador Mena; Miguel A Asensi; José M Estrela; Angel L Ortega Journal: Oxid Med Cell Longev Date: 2015-12-21 Impact factor: 6.543
Authors: Jin Li; Xia Hua; Lili Zhang; Fan Lu; Terry G Coursey; Stephen C Pflugfelder; De-Quan Li Journal: Sci Rep Date: 2016-01-14 Impact factor: 4.379
Authors: Elena Obrador; Rosario Salvador-Palmer; Ali Jihad-Jebbar; Rafael López-Blanch; Thanh H Dellinger; Ryan W Dellinger; José M Estrela Journal: Antioxidants (Basel) Date: 2021-03-21